Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
Malmberg K, Rydén L, Hamsten A, Herlitz J, Waldenström A, Wedel H. Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. Cardiovasc Res. 1997;34:248-253.
Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1012.
Levetan CS, Magee MF. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2003;29:745-771.
Mesotten D, Van den Berghe G. Clinical potential of insulin therapy in critically ill patients. Drugs. 2003;63:625-636.
American Association of Clinical Endocrinologists. Position statement: American College of Endocrinology Consensus Development Conference on Inpatient Diabetes and Metabolic Control. 2003. Available at: www.aace.com/pub/ICC/inpatientStatement.php. Accessed December 22, 2003.
Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-982.
Pomposelli JJ, Baxter JK, Babineau TJ, et al. Early post operative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr. 1998;22:77-81.
Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic review. Lancet. 2000;355:773-778.
Bolk J, van der Ploeg TJ, Cornel JH, Arnold AER, Sepers J, Umans VAVM. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol. 2001;79:207-214.
Malmberg K, for the DIGAMI (Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515.
Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-362.
Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31:359-366.
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein H. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients. Stroke. 2001;32:2426-2432.
Bruno A, Biller J, Adams HP, Clarke WR, Woolson RF, Williams LS, et al. Acute blood glucose level and outcome from ischemic stroke. Neurology. 1999;52:280-284.
Pulsinelli WA, Levy DE, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med. 1983;74:540-544.
Demchuk AM, Morgenstern LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999;30:34-39.
Williams LS, Rotich J, Qi R, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59:67-71.
Scott JF, Robinson GM, French JM, O’Connell JE, Alberti KGMM, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia. Stroke. 1999;30:793-799.
Parsons MW, Barber A, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20-28.
Zerr KJ, Furnary AP, Grunkelmeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetes after open heart operations. Ann Thorac Surg. 1997;63:356-361.
Albert Starr Academic Center for Cardiac Surgery. The Portland Protocol for Continuous Intravenous Insulin Infusion in Post Operative Diabetic Cardiac Surgery Patients. March 2001. Available at: www.starrwood.com/research/insulin.html. Accessed March 17, 2004.
Schiff RL, Emanuele MA. The surgical patient with diabetes mellitus: guidelines for management. J Gen Intern Med. 1995;10:1154-1161.
McMahon MM, Rizza RA. Concise review for primary-care physicians: nutrition support in hospitalized patients with diabetes mellitus. Mayo Clin Proc. 1996;71:587-594.
Hirsch IB, Paauw DS. Diabetes management in special situations. Endocrin Metab Clin North Am. 1997;26:631-645.
Clement S, Still JG, Kostutic G, McAllister RG. Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes: the glucose stabilization effects of HIM2. Diabetes Technol Ther. 2002;4:459-466.
